Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 May 2018 Photo Rulanzen Martin
UFSAfricaWeek Make this Africa Day a day of reflection - Dr Stephanie Cawood
Dr Stephanie Cawood is the acting Director of the CGAS

On 25 May 2018, we celebrate the 55th Africa Day since the Organisation of African Unity (OAU) was formed on this day in 1963. The conception of Africa Day, however, goes back to 1958 to the First Conference of Independent African States held in Accra, Ghana, hosted by Kwame Nkrumah. It was at that conference where Africa Freedom Day was first proclaimed and celebrated on 15 April to commemorate the progress of the African liberation movement as more and more African states gained independence. When more than 30 heads of state of independent African countries met in Addis Ababa, Ethiopia, to form the OAU (now the African Union) on 25 May 1963, African Freedom Day was dubbed African Liberation Day and moved to May. Today, known as Africa Day, it is commemorated across the African continent and the diaspora. 

What is the significance of Africa Day more than 50 years after its inception? African countries may have been liberated, but freedom is often qualified and limited by poverty persistent conflict, poor governance, neopatrimonialism, intolerance and other social injustices? Seen through a gender lens, one may well ask whether we have anything to celebrate when African women and sexual minorities carry such a heavy burden in daily struggles for survival and bear the brunt of persistent conflict. 

On this Africa Day, let’s rejoice in all the progress made since that very first commemoration. Let’s revel in all the vibrant cultural diversity in Africa and its diaspora, but let’s make this Africa Day a day of remembrance and reflection. As a day of remembrance, Africa Day should remind us of the liberation struggles that came before and it should prompt us to reflect on the struggles that remain in areas like gender equality and LGBTQI rights, poverty and sustainable livelihoods, social and environmental injustice, economic dependency, and conflict and what we can do to help effect change for the better. To quote an African proverb, “Use your tongue to count your teeth” for it is only through deep reflection that one will realise what needs to be done and how one should do it.    


This article was written by Dr Stephanie Cawood from the Centre for Gender and Africa (CGAS) Studies at the University of the Free State

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept